New study aims to decode BRCA breast cancer biology for smarter treatment
Knowledge-focused
Recruiting now
This observational study will analyze tumor tissue from 100 people with BRCA1 or BRCA2 mutations and HR-positive, HER2-negative breast cancer. Researchers want to see if different molecular subtypes are linked to how well patients respond to hormone therapy or CDK4/6 inhibitors. …
Sponsor: Angela Toss • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC